Development of drugs for Epstein–Barr virus using high-throughputin silicovirtual screening-Reference-Cited by-同舟云学术

Development of drugs for Epstein–Barr virus using high-throughputin silicovirtual screening

Published:2010-11-20 Issue:12 Volume:5 Page:1189-1203
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Li Ning,Thompson Scott,Jiang Hualiang,Lieberman Paul M,Luo Cheng

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460441.2010.524640

Reference126 articles.

1. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

2. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

3. Epstein–Barr Virus Infection

4. Epstein–Barr virus: 40 years on

5. Kieff E. Epstein-Barr virus and its replication. Fields BN, Knipe DM, Howley PM, editors. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia; 2007:2v:xix, 3091, 86 p

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Momordica anti-HIV protein MAP30 abrogates the Epstein-Barr virus nuclear antigen 1 dependent functions in host cells;Heliyon;2023-11

2. Momordica Anti-Hiv Protein Map30 Abrogates the Persistent Infection of an Oncogenic Human Herpesvirus in Host Cells;2023

3. Report of the 24th Meeting on Signal Transduction 2021;International Journal of Molecular Sciences;2022-02-11

4. Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections;Frontiers in Cellular and Infection Microbiology;2021-03-19

5. Cancer: Seeing the ebb of a tumour virus;Nature Biomedical Engineering;2017-04